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BIOSINTESIS LIPID ENDOSOM-SPESIFIK 
BIS(MONOASILGLISERO)FOSFAT 
 
ABSTRAK 
 
Hipotesis menyatakan laluan biosintetik de novo endosom-spesifik 
bis(monoasilglisero)fosfat (BMP) daripada perintis fosfatidylgliserol (PG) endogen 
melalui perantara lysofosfatidylgliserol (LPG) telah dipertimbangkan. Dalam kajian 
ini, laluan biosintetik alternatif BMP daripada PG melalui perantara 
asilfosfatidylgliserol (AcPG) dicadangkan. Suatu kuantiti AcPG yang agak ketara 
didapati berada dalam dan luar sel sepanjang 24 jam pengeraman dengan PG 
eksogen. Enzim transasilase adalah diperlukan untuk memindah suatu rantai asil 
daripada penderma PG kepada penerima PG, maka menukarkan penerima PG kepada 
AcPG dan penderma PG kepada LPG. Untuk melengkapkan biosintesis BMP yang 
melibatkan laluan AcPG, langkah orientasi semula moieti gliserol dwi-asil mesti 
berlaku seiring dengan kehilangan sisa asil. Cadangan laluan penukaran PG kepada 
BMP melalui activiti transasilase yang menghasilkan AcPG telah disahkan melalui 
assai in vitro dengan menggunakan serum foetal bovin (FBS). Aktiviti transasilase 
yang menyerupai fosfolipase A1 dikenalpasti dengan menggunakan PO PG yang 
tidak simetri sebagai penerima dan penderma, maka menghasilkan PO-P AcPG : PO-
O AcPG pada nisbah 10:1. Selanjutnya, aktiviti transasilase dicirikan dari segi ion 
dwivalen, pH dan spesifikasi substrat. Eksperimen-eksperimen in vitro menggunakan 
koktel enzim yang dirembes daripada sel RAW 264.7 dalam keadaan kebuluran 
menunjukkan kehadiran kedua-dua aktiviti enzim yang dicadangkan, aktiviti 
transasilase dan orientasi semula. Pada masa pertengahan, jumlah kuantiti PG, BMP 
dan AcPG adalah kurang secara ketara berbanding dengan kuantiti PG yang 
dibekalkan pada masa permulaan atau jumlah BMP yang dihasilkan selepas 
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pengeraman selama 24 jam. Peningkatan kuantiti TAG dalam sel menandakan PG 
boleh ditukarkan kepada TAG melalui DAG untuk menyimpan asid-asid lemak 
berlebihan yang disalurkan kepada sel. Pada peringkat yang seterusnya, sebahagian 
TAG digunakan untuk sintesis de novo BMP. Langkah-langkah pemecahan yang 
bersiri telah dikenalpasti untuk menulenkan aktiviti transasilase daripada FBS, 
bermula daripada pemendakan ammonium sulfat, kromatografi turus oktil sefaros 
dan Q sefaros. Identiti protein daripada pecahan yang diperkaya dengan activiti 
transasilase dilakukan melalui analisis proteomik LC-MS dan permadanan 
berdasarkan database bovin dilakukan. Calon protein yang teramat dikenalpasti 
sebagai vanin 1 dan berberat molekul ialah 56.9 kDa. Secara menariknya, analisis 
proteomik supernatan sel RAW 264.7 dalam keadaan kebuluran menunjukkan 
kehadiran sekumpulan lipase yang dirembes, seperti fosfolipase A2, fosfolipase C 
dan fosfolipase D.   
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BIOSYNTHESIS OF ENDOSOME-SPECIFIC LIPID 
BIS(MONOACYLGLYCERO)PHOSPHATE 
 
ABSTRACT 
 
The hypothetical de novo biosynthetic pathway of endosome-specific 
phospholipid, bis(monoacylglycero)phosphate (BMP) from endogenous 
phosphatidylglycerol (PG) precursor via lysophosphatidylglycerol (LPG) 
intermediate had been considered. In the present study, an alternative BMP 
biosynthetic route from PG via acylphosphatidylglycerol (AcPG) intermediate was 
proposed. A considerable amount of AcPG was found present in and outside the 
RAW 264.7 cells during 24 hours of incubation with exogenous PG. A transacylase 
is required to transfer an acyl chain from a PG donor to a PG acceptor, transforming 
the acceptor PG into AcPG and the donor PG into LPG. To complete the BMP 
biosynthesis following the AcPG route, a reorientation step of the diacylated glycerol 
moiety has to occur with concomitant loss of an acyl residue. The new pathway of 
PG conversion to BMP via AcPG forming transacylase activity was established by 
an original in vitro assay utilizing fetal bovine serum (FBS) as enzymatic source. A 
phospholipase A1 displaying a transacylase activity was revealed by utilizing 
asymmetric PO PG as acceptor and donor, yielding a PO-P AcPG:PO-O AcPG ratio 
of 10:1. This transacylase activity was further characterized in terms of divalent ions, 
pH and substrate specificity. In vitro experiments utilizing the secreted enzyme 
complex from RAW 264.7 cells grown under starvation conditions indicated that 
both proposed enzymatic activities, transacylase and reorientation, were present. At 
intermediate time points, the combined amount of PG, BMP and AcPG was 
significantly less compared to the amount of supplied PG at the beginning or the total 
BMP amount produced after 24 hours of incubation. An elevation in triacylglycerol 
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amount in the cell after 8 hours of incubation indicated that PG could be converted to 
triacylglycerol via diacylglycerol to store temporarily the excessive amount of fatty 
acids provided to the cells. At a later stage, a part of the stored triacylglycerol is used 
for the de novo synthesis of BMP. Fractionation steps were established to purify the 
extracellular transacylase activity from FBS, using ammonium sulfate precipitation, 
octyl sepharose and Q sepharose column chromatography. Protein identification of 
the fractions enriched with transacylase activity was performed by LC-MS 
proteomics analysis and matched against a bovine database. The most potent 
candidate protein was identified as vanin 1 with a molecular weight of 56.9 kDa. 
Interestingly, proteomics analysis of the supernatant of starved RAW 264.7 cells 
disclosed the presence of a pool of secreted lipases such as phospholipase A2, 
phospholipase C and phospholipase D. 
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CHAPTER 1 
LITERATURE REVIEW 
 
1.1 Lipid overview  
Lipids are naturally occurring organic compounds which are soluble in 
organic solvent but are immiscible in water (Fahy et al., 2005). Lipids are often 
referred to as fat if their physical appearance at room temperature is solid and called 
oil if it is liquid (Kent, 2000; Caballero, 2006). Lipids are distinct from proteins, 
carbohydrates and nucleic acids with respect to the incredible heterogeneity of their 
molecular structure. In principle, cellular metabolites are categorized predominantly 
according to their solubility as lipids rather than due to specific structural features 
(O’Keefe, 2002; Fahy et al., 2005; Stoffel, 2012). As lipids are at the intersection of 
biology and chemistry, an unambiguously nomenclature suitable for both fields is 
important. Consequently, lipid nomenclature is jointly defined by the International 
Union of Pure and Applied Chemistry (IUPAC) and International Union of 
Biochemistry and Molecular Biology (IUBMB) and outlined at 
http://www.chem.qmul.ac.uk/iupac/ website (Fahy et al., 2005; Fahy et al., 2009).  
Lipids are categorized into eight major classes, including fatty acyls/fatty 
acids, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, 
saccharolipids and polyketides. The representative structure for each of the lipid 
class is depicted in figure 1.1. While fatty acids exhibit limited complexity, 
polyketides, sterols and saccharolipids exhibit a significant level of complexity.  
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(1) Fatty acids: hexadecanoic acid 
 
 
(2) Glycerolipids: 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol 
 
       
(3) Glycerophospholipids: 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
phosphocholine   
 
 
 
 
(4) Sphingolipids: N-(tetradecanoyl)-sphing-4-enine    
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(5) Sterol lipids: cholest-5-en-3β-ol             
 
(6) Prenol lipids: 2E, 6E-farnesol 
   
(7) Saccharolipids: UDP-3-O-(3R-hydroxy-Tetradecanoyl)-αD-N-acetylglucosamine 
 
 
(8) Polyketides: aflatoxin B1 
 
Figure 1.1: Representative structure for each of the lipid classes (Fahy et al., 2005)
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Based on the lipid nomenclature as defined by the IUPAC-IUBMB, it is 
noteworthy to highlight few key features relevant to this study as follows:  
1. The stereospecific numbering (sn) is applied to describe glycerolipids and 
glycerophospholipids. Commonly, the sn-1 and/or sn-2 position are 
acylated, while the sn-3 position is phosphorylated in mammalian and 
bacterial glycerolipids. 
2. The employment of R/S nomenclature (as opposed to α/β) is utilized to 
emphasize difference in the stereochemical configuration of the glycerol 
backbone. 
3. The common term “lyso”, implying that one of the acyl/alkyl groups is 
not present in glycerolipids and glycerophospholipids, it will not be 
utilized in systematic names, but will be included as a synonym to 
improve readability (Moss, 1976; Fahy et al., 2005). 
The definition of stereospecific numbering is as follows: The carbon atom at 
the top in the Fischer projection of the glycerol backbone with the hydroxyl group at 
carbon-2 pointing to the left is designated as C-1. To distinguish stereospecific 
numbering from conventional numbering lacking steric information, the prefix “sn” 
is used. Importantly, the use of stereospecific numbering is only limited to 
glycerolipids and glycerophospholipids (Moss, 1976).  
In general, each carbon atom with different substituent is considered a chiral 
center. A chiral molecule can have one or more chiral centers. A molecule with 
multiple chiral centers is a chiral if it is not superimposable with its mirror image. 
Two molecules which are the exact mirror image of each other are considered 
enantiomer. To clearly define the molecular structure in a standardized manner, 
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Cahn-Ingold-Prelog (CIP) rule should be applied to differentiate between R and S 
configuration of the stereocenter under consideration. The steps are:  
1. The order of the substituents is according to the priority from 1 to 4 (or ‘a’ to 
‘d’ as shown in the example below), with 1 assigned to the substituent with 
the highest molecular weight, and 4 with the lowest. Break ties by taking 
substituents of equal atoms in a stepwise procedure into consideration. 
2. Rotate the molecules so that the substituent of lowest molecular weight is 
facing away from you, thus the molecule is viewed down the bond from the 
chiral center to the lowest priority group. 
3. The handedness is assigned based on the sequence of priority read around the 
chiral carbon atom. If the priority of the atoms from 1-3 is read in a 
counterclockwise direction, the chiral carbon atom is considered left handed 
and named as S enantiomer. S stands for ‘sinister’, meaning in Latin is left. If 
the priority of the atoms from 1-3 are read in a clockwise direction, the center 
is considered right handed and named as R enantiomer. R stands for ‘rectus’, 
meaning in Latin is right. 
A practical example how to determine S and R enantiomers is shown in 
figure 1.2 (Willock, 2009).  
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 Figure 1.2: Assignment of S and R enantiomers following CIP rules. In this example 
the priority groups are read a >b >c >d (Willock, 2009) 
 
Commonly, lipid structures tend to be drawn from left to right. In case of 
simple fatty acids or prenol building blocks, the acid carboxyl or hydroxyl group is 
thus drawn on the right and the hydrophobic hydrocarbon tail is drawn on the left, as 
shown in figure 1.1. Similarly, in glycerolipids and glycerophospholipids, the 
hydrocarbon chains tend to be drawn on the left and the glycerol moiety is drawn 
horizontally, similar to Fischer projection, providing direct visualization of the 
stereochemistry (if known). In contrast to glycerophospholipids, sphingolipids lack a 
glycerol moiety. Nonetheless, the head groups of glycerophospholipids and 
sphingolipids tend to be depicted on the right and the hydrocarbon tails tend to be 
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depicted on the left. Inevitably, structurally complex lipids cannot adhere to this 
common guideline, such as sterol, saccharolipids and polyketides (Fahy et al., 2005). 
Nevertheless, liberal exception can and will be applied throughout this dissertation. 
To support advances in lipid biology and lipidomics large repertoires such as 
LIPIDAT and Lipid Bank have been established. LIPIDAT and Lipid Bank provide 
catalog, annotation and functional classification of lipids (Fahy et al., 2005). 
Lipids serve as the primary energy storage in living organisms by supplying 
more than twice the energy per gram compared to carbohydrates (van Meer et al., 
2008). In addition, lipids function as heat insulation, shock absorption and buoyancy 
(Kent, 2000). Lipids play crucial roles as mediators for signal transmission in many 
cellular pathways. Lipids are also involved in cell differentiation as well as hormone 
and cytokine synthesis (Caballero, 2006; Eyster, 2007). 
Fatty acids are the simplest molecules among lipids. Their structure and 
nomenclature are illustrated in figure 1.3 and table 1.1, respectively (Fahy et al., 
2005). 
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Figure 1.3: Structure of a fatty acid chain which consists of a carboxyl head group 
and a hydrocarbon tail (Fahy et al., 2005) 
 
Table 1.1 Physiologically relevant fatty acids (Fahy et al., 2005) 
Number of 
carbons 
Number of 
double bonds 
Numerical Symbol/ 
Shorthand 
Common name 
14 0 14:0 Myristic acid/ Myristate 
16 0 16:0 Palmitic acid/ Palmitate 
16 1 16:1Δ9 Palmitoleic acid/ Palmitoleate 
18 0 18:0 Stearic acid/ Stearate 
18 1 18:1Δ9 Oleic acid/ Oleate 
18 2 18:2Δ9,12 Linoleic acid/ Linoleate 
18 3 18:3Δ9,12,15 α-Linolenic acid (ALA)/ 
Linolenate 
20 4 20:4Δ5,8,11,14 Arachidonic acid/ 
Arachidonate 
20 5 20:5Δ5,8,11,14,17 Eicosapentaenoic acid (EPA) 
22 6 22:6Δ4,7,10,13,16,19 Docosahexaenoic acid (DHA) 
 
Note: The position of double bonds is indicated by Δn, where n indicates lower 
numbered carbon of each pair. 
 
Most mammalian fatty acids have an even number of carbon atoms and 
ranging between 12-22 carbons. DHA is an example of a common polyunsaturated 
fatty acid. In general, fatty acids are denoted by a numerical symbol or shorthand 
description, as shown in table 1.1. For example, 18:1 for oleic acid which implies 18 
carbon atoms and 1 double bond in the acid chain, commonly at position delta 9. The 
non polar hydrocarbon chain and the polar carboxyl group confer the amphipathic 
Carboxyl 
group 
Hydrocarbon 
tail 
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nature of lipids, resulting in the spontaneous self assembly of lipids and the 
formation of small vesicular or lamellar arrangements in aqueous environment (van 
Meer et al., 2008; Bohdanowicz and Grinstein, 2013). Not all lipids exhibit polar 
amphipathic nature. For example, the uncharged neutral lipids include fatty acid 
esters (carbon atom more than 12), mono-, di-, triacylglycerols, sterols, sterol esters 
and prenols (O’Keefe, 2002). 
Liposomes are artificial vesicles that exhibit a phospholipid bilayer 
arrangement, mimicking the biological membrane up to a certain degree. Importantly, 
the lipid composition can be changed easily according to the experimental design. 
Figure 1.4 displays the schematic illustration of liposomes of different sizes, 
including small unilamellar vesicle (SUV), large unilamellar vesicle (LUV), 
multilamellar vesicle (MLV) and multivesicular vesicle (MVV). The liposomal sizes 
of SUV and LUV are 20-100 nm and 100-400 nm, respectively. Whereas the 
liposomal sizes of MLV and MVV fall in the range of 200 nm to approximately 3000 
µm. 
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Figure 1.4: Schematic illustration of liposomes of different sizes, including small  
unilamellar vesicle (SUV), large unilamellar vesicle (LUV), 
multilamellar vesicle (MLV) and multivesicular vesicle (MVV) 
(http://www.azonano.com/article.aspx?ArticleID=1243) 
 
 
1.2 Membrane phospholipids 
The fluid mosaic model of the structure of cell membranes proposed by 
Singer and Nicolson was the first step towards a better understanding of the 
importance of lipids and has been widely accepted (Singer and Nicolson, 1972). 
Lipids, proteins and carbohydrates are the biological molecules which form the 
architecture of the plasma membranes. At the most rudimentary level, the cell 
membrane is constituted of a lipid bilayer with the polar hydrophilic head of each 
lipid molecule facing either towards the cytoplasm or extracellular matrix, while 
their hydrophobic tails face towards each other. Integral membrane proteins are 
embedded in this membrane bilayer, while peripheral proteins form transient 
interactions with lipid bilayer. Carbohydrates are either covalently attached to the 
protein as glycoproteins or to lipids as glycolipids (saccharolipids) and are involved 
in cellular physiology (Singer and Nicolson, 1972; Eyster, 2007).   
Bilayer of 
phospholipids 
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The lipid composition of each subcellular organelle and the plasma 
membrane varies according to the specific task performed at each of the subcellular 
compartment. For instances, plasma membranes are enriched in sterols and 
sphingolipids, less abundant in phospholipids in order to confer mechanical strength 
to the cells (van Meer et al., 2008). The heterogeneous distribution of lipids and 
proteins over the membranes and the spatial and temporal lipid-protein interaction 
attributed to the function of membranes in living cells (Smith, 2012). Lipid-lipid 
immiscibility results in lateral heterogeneity of the membrane leaflet, often called 
lipid raft. Lipid rafts or microdomains are broadly defined as liquid-ordered 
membrane domains in which the lipids are more tightly packed compared to the 
surrounding non-raft bilayer. The high packing of raft is due to the saturated 
hydrocarbon chains in raft phospholipids and sphingolipids (Rajendran and Simons, 
2005).    
Glycerophospholipids or in short, phospholipids are one of the main 
constituents of all cell membranes displaying a great diversity (Hermansson et al., 
2011). Phospholipids constitute the bulk of the cellular membrane lipids, including 
phosphatidic acid (PA), phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS), phosphatidylglycerol (PG), phosphatidylinositol (PI), 
cardiolipin (CL), lysophosphatidic acid (LPA) and lysobisphosphatidic acid (LBPA), 
also known as bis(monoacylglycero)phosphate (BMP) (van Meer et al., 2008). The 
amphipathic nature of phospholipids allows cells and subcellular organelles to be 
separated or compartmentalized by membranes. Lipid membranes act not merely as 
highly selective physical barrier in and between cells, but play a central role in 
numerous metabolic processes (Escriba et al., 2008; van Meer et al., 2008). Figure 
1.5 displays the representative structure of common phospholipids. The glycerol 
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backbone of phospholipids (as outlined with green box) is usually esterified with two 
fatty acyl chains at sn-1 and sn-2 position, respectively (highlighted by a purple box). 
The head group (represented by “X”) is linked via a phosphate residue (outlined with 
a blue box) to the sn-3 position of the glycerol backbone. The head group of 
phospholipids gives rise to the name of each phospholipid. The phospholipids shown 
in figure 1.5 encompass PA, PC (also called lecithin), PE, PS, PI and PG (Kelly and 
Jacobs, 2016). Two letter abbreviations are commonly used to identify phospholipid 
subclasses.  
 
Figure 1.5: Representative structures of common phospholipids (Kelly and Jacobs, 
2016) 
 
1.3 Biosynthesis of phospholipids  
Lipids are produced, transported, recognized and degraded by a variety of 
enzymes, binding proteins and receptors (Fahy et al., 2005). Within the eukaryotic 
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cells, the synthesis of a particular lipid is often organelle-specific. The endoplasmic 
reticulum (ER) is the primary location for the synthesis of a large number of lipids 
such as functional phospholipids and cholesterol. CL and BMP are considered 
exclusively synthesized in the mitochondrial and endosomal membrane, respectively. 
Triacylglycerol (TAG) and cholesteryl ester (CE) are produced at the ER. 
Sphingolipid synthesis is completed in the Golgi apparatus. As phospholipids and 
sphingolipids are found in all cellular membranes, these lipids have to be exported 
from their site of synthesis to their target organelles, requiring an efficient packing 
and sorting mechanism. The Golgi apparatus acts as the major lipid sorting site (van 
Meer et al., 2008). 
The biosynthesis of the main constituents of the phospholipid membrane is 
very different between archaea, bacteria and eukaryotes, as deciphered in figure 1.6 
(Lombard et al., 2012). 
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 Figure 1.6: Comparison of the biosynthetic pathways of phospholipids in archaea,       
bacteria and eukaryotes (Lombard et al., 2012) 
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In bacteria and eukaryotes, phospholipids are composed of glycerol-3-
phosphate (G3P) derivatives. On contrary, phospholipids in archaeal membrane are 
derived from glycerol-1-phosphate (G1P) (Lombard et al., 2012). The 
stereoconfiguration of the glycerophosphoglycerol backbone has attracted special 
interest due to its cellular physiological roles and involvement in the evolution of life 
(Taniguchi et al., 2015). The protein-phospholipid interaction is based on 
electrostatic interaction, which in turn strongly depends on the actual 
stereoconfiguration of both chiral partners. While some phospholipids act as 
substrate, requiring a key-lock type interaction with special emphasize on their 
stereoconfiguration, others act as ligands during signaling processes or are functional 
independent of their interaction with proteins (Bohdanowicz and Grinstein, 2013). 
The phospholipid BMP, the main focus of this dissertation is primarily of 
eukaryotic origin. Consequently, BMP is derived from a G3P precursor. Therefore, 
special emphasis will be put on the biosynthesis of phospholipids derived from G3P.  
 
1.4 Bis(monoacylglycero)phosphate (BMP) 
     1.4.1 Structure and de novo biosynthesis of BMP 
The structure of BMP is depicted in figure 1.7. BMP features a 
glycerophosphoglycerol backbone and both of the glycerol moieties are esterified to 
the central phosphate residue at carbon number-1. Consequently, the BMP backbone 
is featuring a stereoconfiguration number (sn) of sn-1,1’ diglycerophosphate that was 
confirmed recently (Brotherus et al., 1974; Jouti et al., 1976; Jouti and Renkonen, 
1979; Tan et al., 2012). The absence of any cationic charge renders BMP an anionic 
phospholipid, carrying a negative charge on its phosphate head group. Additionally, 
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each side of the glycerol is esterified with a single acyl chain. The length of the acyl 
chains and their saturation degree vary according to the cell type. In cultured 
mammalian cells, the main acyl chain species of BMP is oleic acid, featuring 18 
carbon atoms and a double bond (18:1) (Mason et al., 1972; Brotherus and Renkonen, 
1974; Huterer and Wherrett, 1979; Cochran et al., 1985; Kobayashi et al., 2002; 
Akgoc et al., 2015). The exact location of the acyl chains on both of the glycerol 
moieties of natural BMP is still unclear (Wherrett and Huterer, 1973; Amidon et al., 
1996).   
BMP is a peculiar mammalian phospholipid exclusively displaying an sn-1,1’ 
diglycerophosphate backbone, resembling the phospholipids of the archaeal domain 
(Tan el al., 2012). The unique stereoconfiguration is likely one of the reasons why 
BMP exhibits a considerable stability under the highly acidic lysosomal environment, 
which is rich in lytic enzymes (Appelqvist et al., 2013). In general, the lysosomes are 
regarded as the digestive stomach of cell, based on their ability to digest cellular 
metabolites, such as proteins, nucleotides and lipids into their building blocks 
(Schulze et al., 2009). Not surprisingly, BMP has been reported to be resistant 
against degradation by phospholipases (Matsuzawa and Hostetler, 1979). The 
turnover of the BMP backbone is much slower than the turnover of its acyl chains, 
particularly in case of polyunsaturated fatty acids (Huterer and Wherrett, 1990). The 
unusual stereoconfiguration of BMP reflects its unique physiological roles and 
likewise, its biosynthesis must differ considerably from other phospholipids of  
mammalian origin.  
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Figure 1.7: Stereoconfiguration of BMP: sn-1,1’ diglycerophosphate 
 
 
LPA formation is the first step from G3P during the de novo biosynthesis of 
mammalian phospholipids. Next, LPA is converted to PA by a LPA acyltransferase 
(AGPAT, also known as LPAAT), a short lived key intermediate in phospholipid 
biosynthesis. PA is mainly metabolized into two types of glycerol derivatives. Firstly, 
diacylglycerol (DAG), which is converted to TAG, PC, and PE. PS in turn is 
synthesized from PC or PE. Secondly, cytidine diphosphate-diacylglycerol (CDP-
DAG) is processed into PI, PG, CL, and BMP. The de novo biosynthesis of BMP 
from PA is depicted in figure 1.8, involving CDP-DAG synthase, 
phosphatidylglycerophosphate (PGP) synthase and PGP phosphatase.  
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Figure 1.8: The de novo biosynthesis of BMP from PA. The enzymes catalysing the  
       successive steps from PG to BMP have not been characterized yet. Red    
       squares indicate the altered backbone configuration between PG and   
       BMP 
                      
 
18 
 
Special attention should be paid to the backbone of PG and BMP which is 
highlighted in red dotted line as shown in figure 1.8. The backbone of naturally 
occurring PG is sn-3,1’ diglycerophosphate. Notably, BMP exhibits an sn-1,1’ 
diglycerophosphate backbone (Hullin-Matsuda et al., 2009). Nevertheless, BMP is 
not just a simple structural isomer of PG and the conversion of PG to BMP is not a 
straight forward process (Thornburg et al., 1991; Hullin-Matsuda et al., 2014). 
Extended scientific interest and discussion clarified that the reorientation of the 
glycerol backbone of PG precursor or more likely one of the synthesis intermediates 
is the key step leading to the biosynthesis of BMP with its unusual 
stereoconfiguration (Somerharju and Renkonen, 1980; Frentzen-Bertrams and 
Debuch, 1981; Amidon et al., 1995). To-date it is not clear whether the mechanism 
resulting in glycerol backbone reorientation is facilitated by a single or a set of 
enzymes (Thornburg et al., 1991).  
 
1.4.2 Cellular localization and biological roles of BMP 
BMP is an endosome-specific phospholipid which is found primarily in the 
late endosomal and lysosomal organelles of mammalian cells (Kobayashi et al., 
1998). BMP is highly enriched in the internal membranes of late endosomes 
accounting for up to 15 % of total late endosomal phospholipids (Kobayashi et al, 
2002; Hullin-Matsuda et al., 2009). BMP content, which is less than 1 % of total 
cellular phospholipids, strongly depends on the culture conditions and cell line or 
tissue types (Frederick et al., 2009; Akgoc et al, 2015). Late endosomes play a 
decisive role for incoming material in the endocytic pathway and outgoing 
components to the lysosomes, the Golgi complex or the plasma membrane, as shown 
in figure 1.9 (Scott et al., 2014). Endocytosis is the general term defined as the 
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internalization process of solutes, fluid, macromolecules and plasma membrane 
components. The endocytosis mechanism is initiated by plasma membrane 
invagination, followed by membrane fission, budding off the membrane and 
transport of the resulting vesicle via early endosomes, multivesicular bodies to late 
endosomes, and finally lysosomes (Huotari and Helenius, 2011).   
 
Figure 1.9: Endocytosis via early endosome, late endosome and lysosome (Scott et 
al., 2014) 
 
Mounting evidence indicates that BMP-rich domains play a crucial role 
during cholesterol homeostasis and glycolipids degradation in late endosomes 
(Chevallier et al., 2008; Schulze et al., 2009). BMP is involved in the lipid and 
protein transport within the endosomal system after their delivery via endocytosis or 
autophagy (Kobayashi and Hirabayashi, 2000; Hullin-Matsuda et al., 2009). 
Additionally, BMP is involved in the formation of the archetypal multivesicular 
bodies during the endosomal maturation. These internal membranes are rich in BMP 
and are considered to exhibit specific properties favoring digestion based on the 
physical properties of BMP. Additionally, BMP provides structural organization for 
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formation and stability of multivesicular bodies (Frederick et al., 2009; Kolter and 
Sandhoff, 2010). 
 
1.4.3 Proposed biosynthetic pathway of BMP from PG  
1.4.3(a) Phospholipase and transacylase 
Hydrolases are an important class of enzymes and represent a significant 
proportion of cellular proteins. They are generally implicated in degradative process 
but also in many physiological processes, such as signaling. Utilizing a molecule of 
water as acceptor, hydrolases cleave carbon-hetero atom bonds such as esters, ethers 
and acetyls. Depending on substrate specificity, hydrolases are subcategorized into 
nucleases (nucleic acids), proteases (proteins), glycosidases (carbohydrates or sugars), 
phosphatases (phosphate esters) and lipases (lipids). Additionally, hydrolases can be 
classified according to the functional group affected, such as carbon ester hydrolases, 
phosphate ester hydrolases, pyrophosphate ester hydrolases, phosphodiester 
hydrolases and amide hydrolases (Dennis, 2015).  
The first step involved in the biosynthetic pathway of BMP from its PG 
precursor is the cleavage of the sn-2 acyl chain of PG by a phospholipase (PLA) 
(Waite et al., 1990; Amidon et al., 1995). Phospholipases belong to the large group 
of hydrolases and catalyze the hydrolysis of acyl esters (acyl hydrolases) or 
phosphate esters (phosphodiesterase) on phospholipids (Dennis, 2015). 
Phospholipases are further classified according to the position they hydrolyze on the 
phospholipid backbone. Phospholipase A1 (PLA1), phospholipase A2 (PLA2), 
phospholipase B (PLB) and lysophospholipase A1/2 (lysoPLA1/2) are the acyl 
hydrolases, whereas phospholipase C (PLC) and phospholipase D (PLD) constitute 
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the phosphodiesterases, as shown in figure 1.10. PLA1, PLA2 and PLC cleave the 
ester bonds connecting to carbon at sn-1, sn-2 or sn-3 position, respectively. PLD 
catalyzes the hydrolysis of phospholipids at the phosphodiester bond, adjacent to the 
PLC sensitive phosphate ester bond. PLB hydrolyzes both the sn-1 and sn-2 ester 
bonds, while lysoPLA1/2 can be either specific for the sn-1 or sn-2 ester bond or 
cleave both with same affinity, but in any case they utilize only lysophospholipids as 
substrate (Richmond and Smith, 2011). 
Phospholipases are ubiquitously expressed in all tissues and take a variety of 
forms, such as soluble proteins usually secreted from cells, membrane associated or 
restrained to specific intracellular compartments. While some require cofactors for 
activity, others are activated at specific pH environment. Phospholipases exhibit 
large variety of functions and can be categorized into three main functions: (1) as 
digestive enzymes breaking down phospholipids and thus regulating the turnover of 
phospholipids; (2) as phospholipases responsible to maintain membrane integrity by 
acyl remodeling. The exchange of acyl chains between phospholipids occurs 
frequently in living cells and is catalyzed by acyl hydrolases or acyltransacylases. 
Consequently, transfer of acyl chains between phospholipids increases phospholipid 
diversity and can play a decisive role in cellular physiological pathways; (3) as 
phospholipases contributing to the production of bioactive lipid mediators, such as 
for signal transduction. Among phospholipases, PLA2, PLC and PLD are the most 
established lipases involved in the formation of bioactive lipid molecules (Richmond 
and Smith, 2011). 
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 Figure 1.10: Ester bond specificity of phospholipases (Richmond and Smith, 2011) 
 
In addition to phospholipase-dependent hydrolysis, acylation takes place 
during the biosynthesis of BMP from PG and is catalyzed by transacylase (TA) and 
acyltransferase. Transacylase is generally defined as the enzyme catalyzing the 
transfer of acyl groups esterified in phospholipids to lysophospholipids without the 
generation of free fatty acids (Yamashita et al., 1997; Yamashita et al., 2014). 
Transacylases are CoA-dependent or CoA-independent. Acyltransferase catalyzes 
the transfer of an acyl group from an acyl-CoA to any of various acceptors (Shindou 
and Shimizu, 2009; Hishikawa et al., 2014; Yamashita et al., 2014).  
The proposed pathway for the biosynthesis of BMP from PG is shown in 
figure 1.11. A PLA2 cleaves the sn-2 acyl chain of PG (as highlighted in the green 
box) to form sn-3:sn-1’LPG (step 1). Next, LPG is acylated at the head group 
glycerol by a transacylase, using a phospholipid as the acyl donor to form sn-3:sn-
1’BMP (step 2). Subsequently, the backbone of BMP is reoriented from sn-3:sn-
1’BMP to sn-1:sn-1’LPG (step 3), but the mechanism is still largely elusive. Next, 
sn-1:sn-1’LPG is acylated by a transacylase to yield sn-1:sn-1’BMP (step 4) 
(Amidon et al., 1995). 
PLA1 PLC 
PLA2 PLD 
PLB/ 
LysoPLA 
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 Figure 1.11: Proposed biosynthetic pathway of BMP from PG. PLA2: Phospholipase 
A2; TA: Transacylase; PL: Phospholipid; LPL: Lysophospholipid; ROE: 
Reorientation of enzyme (Amidon et al., 1995) 
 
Additionally, alternatives route for the biosynthesis of BMP have been 
proposed as depicted in figure 1.12. In hypothesis (1), deacylation/hydrolysis of PG 
leads to the formation of LPG, followed by the transfer of an acyl chain to the head 
group glycerol of LPG to form BMP, while the reorientation of the backbone occurs 
either during the first or second step. In hypothesis (2), an acyl chain is first 
transferred from an acyl donor to the head group glycerol of PG yielding an acyl 
phosphatidylglycerol (AcPG), followed by deacylation and concomitant re-
orientation to form BMP. The acylation process would be independent of acyl-CoA. 
Hypothesis (3) seems possible, though no experimental evidence to-date has been 
presented in its support (Poorthuis and Hostetler, 1976). 
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